The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy

The prognosis value of CONUT and SIS score for recurrent or metastatic esophageal squamous cell carcinoma patients treated with second-line immunotherapy

ObjectiveTo investigate the predictive value of Controlling Nutritional Status (CONUT) score and systemic inflammation (SIS) score in the prognosis, short-term efficacy, and immune-related side effects of patient with recurrent or metastatic esophageal squamous cell carcinoma (R/M ESCC) receiving im...

Full description

Bibliographic Details
Main Authors: Xiao-Han Zhao, Wen-Bin Shen, Duo Wang, He-Song Wang, Chun-Yang Song, Wen-Zhao Deng
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-06-01
Series:Frontiers in Oncology
Subjects:
esophageal squamous cell carcinoma
second-line treatment
immune checkpoint inhibitors
controlling nutritional status
systemic inflammation score
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1167625/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1167625/full

Similar Items